Heterologous prime-boost immunotherapy of melanoma patients with Influenza virosomes, and recombinant Vaccinia virus encoding 5 melanoma epitopes and 3 co-stimulatory molecules. A multi-centre phase I/II open labeled clinical trial
Titel:
Heterologous prime-boost immunotherapy of melanoma patients with Influenza virosomes, and recombinant Vaccinia virus encoding 5 melanoma epitopes and 3 co-stimulatory molecules. A multi-centre phase I/II open labeled clinical trial
Auteur:
Adamina, Michel Weber, Walter P. Rosenthal, Rachel Schumacher, Reto Zajac, Paul Guller, Ulrich Frey, Daniel M. Oertli, Daniel Zuber, Markus Heberer, Michael Spagnoli, Giulio C.